Viewing Study NCT00524069


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-01-02 @ 9:37 AM
Study NCT ID: NCT00524069
Status: WITHDRAWN
Last Update Posted: 2013-02-01
First Post: 2007-08-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Sponsor: Roswell Park Cancer Institute
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: I 68805
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View